Investment Securities (Tables)

9 Months Ended

Jun. 30, 2016

Accounting Policies [Abstract]

Comprehensive Income

8,066,667	Common Shares of Entest Biomedical, Inc.
Basis		Fair Value	Total Unrealized Losses in Other Comprehensive Income		Net Unrealized Gain or (Loss )realized during the quarter  ended June 30, 2016
195,000		80,667	(114,333	)	23,393